WHO ICTRP trial
A prospective, multicentre, open-label, centrally allocated, active-controlled…
EUCTR2013-000491-14-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2013-000491-14-ES |
|---|---|
| Public title | A prospective, multicentre, open-label, centrally allocated, active-controlled, phase 2 study to evaluate the efficacy and safety of masitinib in combination with gemcitabine versus gemcitabine alone in advanced / metastatic epithelial ovarian cancer patients in second line being refractory to first line platinum treatment or in third line |
| Scientific title | A prospective, multicentre, open-label, centrally allocated, active-controlled, phase 2 study to evaluate the efficacy and safety of masitinib in combination with gemcitabine versus gemcitabine alone in advanced / metastatic epithelial ovarian cancer patients in second line being refractory to first… |
| Primary sponsor | AB Science |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France;United States;Czech Republic;Argentina;Belgium;Spain;Austria;Germany;Italy;United Kingdom |
| Conditions | Advanced/metastatic epithelial ovarian cancer in second line being refractory to first line platinum treatment or in third line MedDRA version: 17.1 Level: PT Classification code 10033158 Term: Ovarian epithelial cancer metastatic System… |
| Interventions | Product Name: masitinib Product Code: AB1010 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: masitinib mesylate CAS Number: 790299-79-5 Current Sponsor code: AB1010 Other descriptive name: MASITINIB Concentration unit: mg/kg… |
| Registration date | Jul 2, 2014 |
| Target size | 56 |
| Secondary IDs | AB12008 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: